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INTRODUCTION 
 
Analytical chemistry, which is both a theoretical and practical science is practiced 
in large number of laboratories in diverse ways. Methods of analysis are routinely 
developed, modified, validated and applied for regular use. It is concerned with providing 
qualitative and quantitative information about the chemical and structural composition of 
a sample of matter. A million levels of drugs in biological tissue, are handled by the 
analyst. The field is huge variety of samples, from high concentrations of elements in 
alloy steels to part-per- founded on the conversion of a measured physical property of the 
species being examined to a usable signal. The overall strategy is to prepare a sample 
correctly, choose a particular method of analysis, and report the results in a meaningful 
format, which may include a statistical evaluation. 
 
Analytical Chemistry deals with methods for determining the chemical 
composition of samples of matter.  A qualitative method yields information about the 
identity and purity of atomic or molecular species or the functional groups in the sample; 
a quantitative method, in contrast, provides numerical information as to the relative 
amount of one or more of these components. Some of the recent analytical application 
includes:  
 
 Determination of oxygen and CO2 levels in millions of blood samples are carried  
            out on a routine day to day basis, to diagnose and treat various ailments.  
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 Estimation of hydrocarbons, nitrogen acids and carbon monoxide present in  
            automobile gases are done to assess the effectiveness of smog control devices. 
 Analysis of calcium levels in blood serum help diagnose parathyroid disease. 
 Protein content and nutritional value of food is established by estimating the  
             nitrogen content. 
 Steel with desired strength, hardness, corrosive resistance and ductility could be  
             Produced by analyzing the concentration of elements such as carbon, nickel and  
             Chromium and suitable manipulation.  
         Quantitative analysis plays a significant role in many research areas in chemistry, 
biology, geology, material science, engineering and medicine. The various technique of 
analytical chemistry is applied in all branches of chemistry (Skoog, et al 2004). 
Analytical chemistry involves two basic divisions.  
                          1. Qualitative analysis  
2. Quantitative analysis  
       Qualitative analysis gives an indication of the identity of the chemical species in 
the sample and quantitative analysis determines the amount of one or more of these 
components. The separation of components is often performed prior to analysis.  
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Analytical methods can be separated into  
 Classical methods 
 Instrumental methods. 
           The separation of materials is accomplished using chromatography or 
electrophoresis methods. Analytical chemistry is also focused on improvements in 
experimental design, chemo metrics, and the creation of new measurement tools to 
provide better chemical information. Analytical chemistry has applications in forensics, 
bioanalysis, clinical analysis, environmental analysis, and material analysis. 
Classical Methods  
 Qualitative analysis 
 Chemical tests 
 Flame test 
 Gravimetric analysis 
 Volumetric analysis 
 
Instrumental methods 
 Spectroscopy  
 Mass spectrometry  
  Electrochemical analysis  
 Thermal analysis  
 Separation  
  Hybrid techniques  
  Microscopy  
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Spectroscopy (http://en.wikipedia.org/wiki/Dual_polarisation_interferometry) 
 
        Spectroscopy measures the interaction of the molecules with electromagnetic 
radiation. It consists of many different applications such as atomic absorption 
spectroscopy, atomic emission spectroscopy, ultraviolet-visible spectroscopy, x-ray 
fluorescence spectroscopy, infrared spectroscopy, Raman spectroscopy, nuclear magnetic 
resonance spectroscopy, photoemission spectroscopy, Mossbauer spectroscopy and so on. 
 
Nuclear Magnetic Resonance 
 
          Nuclear magnetic resonance (NMR) spectroscopy is an analytical procedure based 
on the magnetic properties of certain atomic nuclei. It is similar to other types of 
spectroscopy in that absorption or emission of electromagnetic energy at characteristic 
frequencies provides analytical information. 
 
NMR spectroscopy has been used for a wide range of applications such as 
structure elucidation; thermodynamic, kinetic, mechanistic studies, and quantitative 
analysis. Some of these applications are beyond the scope of compendia methods. (USP 
2004-24). All five characteristics of the signal-chemical shift multiplicity, line width, 
coupling constants, and relative intensity contribute analytical information. 
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NMR spectrum is normally used for the following purpose: 
 
 Identification of analyte 
 Structure elucidiation of analyte 
 To detect  impurities 
 To conduct degradation studies 
 To investigate metabolic pathway 
 
Comparison of spectrum from the literature or from an authentic specimen with 
that of a test specimen may be used to confirm the identity of a compound and to detect 
the QNMR presence of impurities that generate extraneous signals. The NMR spectra of 
simple structures can be adequately described by the numeric value of the chemical shifts 
and coupling constants and by the number of protons under each signal. Presently due to 
availability of high sensitivity/ homogeneity NMR instruments applications of qNMR has 
increased. 
 
QNMR came into practice more than 5 decades ago and first paper on 
pharmaceutical was published in 1963 [D.P.Hollis., et al., (1963) ] NMR spectroscopy is 
a primary ratio method of measurement as the peak areas are proportional to the number 
of corresponding nuclei giving rise to signals. [H.Jancke.,et al., (1998)] .The uncertainty 
in quantification measurement by NMR is low. [G. Maniara., et al., ( 1998 ) The absolute 
amount of substances can be determined by using simple reference substances.  
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The advantages of qNMR are (Torgny Rundlof et al., 2010) as follows: 
 
 Simple and easy sample preparation 
 Possibility to simultaneously determine molecular structure 
 Individual experimental set up is not required. 
 Relatively short measuring time 
 Non invasive and nondestructive method 
 Prior separation of analyte from mixture is not necessary 
 Possibility of simultaneous quantification is of multiple target analyte in a 
mixture. 
 
Quantitative analysis, as well as detection of trace impurities, is markedly improved with 
modern instrumentation. Stronger magnetic fields and the ability to accumulate and / or 
average signals over long periods of time greatly enhance the sensitivity of the method. 
Quantitative Applications 
            If appropriate instrument settings for quantitative analysis have been made, the 
area (or intensities) of two signals are proportional to the total number of protons 
generating the signals 
           A1       N1 
                       ═   
               
A2         N2 
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If the two signals originate from two functional groups of the same molecule, the 
equation can be simplified to  
 
           A1       n1 
                      ═ 
               
A2         n2 
 
In which n1 and n2 are the number of protons in the respective functional groups. If the 
two signals originate from different molecular species. 
                                        A1           n1m1          n1W1/M1 
 ═   ═  
                                        A2          n2m2          n2W2m2 
 
Where m1 and m2 are the number of moles, W1 and W2 are the masses, and M1 and M2 
are the molecular weights of compounds I and 2 respectively. 
 
The above equations indicated that NMR quantitative analysis can be performed 
in an absolute or relative manner. In the absolute method, an internal standard is added to 
the specimen and a resonance peak area from the internal standard. If both test substance 
and internal standard are accurately weighed, the absolute purity of the substance may be 
calculated. The relative method may be used to determine the molar fraction of an 
impurity in a test substance (or of the components in a mixture). 
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Hybrid techniques 
 Combinations of the above techniques produce a "hybrid" or "hyphenated" 
technique. Several examples are in popular use today and new hybrid techniques are 
under development. For example, gas chromatography-mass spectrometry, gas 
chromatography-infrared spectroscopy, liquid chromatography-mass spectrometry, liquid 
chromatography-NMR spectroscopy. Liquid chromagraphy-infrared spectroscopy and 
capillary electrophoresis-mass spectrometry. 
A hyphenated separation technique refers to a combination of two (or more) 
techniques to detect and separate chemicals from solutions. Most often the other 
technique is some form of chromatography. Hyphenated techniques are widely used in 
chemistry and biochemistry. 
Establishment of concentration of analyte 
Standard curve   
A general method for analysis of concentration involves the creation of a 
calibration curve. This allows for determination of the amount of a chemical in a material 
by comparing the results of unknown sample to those of a series known standards. If the 
concentration of element or compound in a sample is too high for the detection range of 
the technique, it can simply be diluted in a pure solvent. If the amount in the sample is 
below an instrument's range of measurement, the method of addition can be used. In this 
method a known quantity of the element or compound under study is added, and the 
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difference between the concentration added, and the concentration observed is the 
amount actually in the sample. 
 Internal standards 
          Sometimes an internal standard is added at a known concentration directly to an 
analytical sample to aid in quantitation. The amount of analyte present is then determined 
relative to the internal standard as a calibrate. 
 Standard addition 
         The method of standard addition is used in instrumental analysis to determine 
concentration of a substance (analyte) in an unknown sample by comparison to a set of 
samples of known concentration, similar to using a calibration curve. Standard addition 
can be applied to most analytical techniques and is used instead of a calibration curve to 
solve the matrix effect problem. 
Statistical Parameters  
         Statistics consists of a set methods and rules for organizing and interpreting 
observations. The precision and reproducibility of the analytical method is determined by 
repeating the analysis. The following statistical parameters were calculated for the 
analytical methods employed.  
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Mean 
         The Mean or average is obtained by dividing the sum of observed values by the 
number of observations (n).  
                                               
n
X
x
∑
=
 
Standard Deviation 
          Standard deviation (SD) is measure of data dispersion or variability. The standard 
deviation gives an idea of how close the entire set of data is to the average value. SD is 
also called root mean square deviation. 
                                                
∑ −−= 1/)( 2 nXXSD
 
Relative Standard Deviation 
          The relative standard deviation (RSD) is also called co-efficient of variation. It is 
defined as  
                                                     
XSDRSD /=
 
                                                     
100% ×=
X
SDRSD
 
Regression Equation 
         A regression is a statistical analysis assessing the association between two 
variables. It is used to find the relationship between two variables.  
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Regression equation                y = mx + c 
Where, m – the slope of regression line 
c– the intercept point of regression line and the y axis 
Standard Error 
         Standard error is a statistical term that measures the accuracy with which a sample 
represents a population. In statistics, a sample mean deviates from the actual mean of a 
population; this deviation is the standard error. Standard error (SE) is given by       
                                          
n
SDSE =
  
Validation 
          It is process which involves confirmation or establishment by laboratory studies 
that a method/procedure gives accurate and reproducible result for the intended analytical 
application in a proven and established range. 
Types of validation (Sethi PD, 2008) 
*  Prospective validation 
*  Retrospective validation 
*  Concurrent      
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Prospective validation:  
          This is employed when historical data of the product is not available. Such 
validation is conducted prior to release of either new product or product made under 
revised/ new manufacturing process where revision may affect the product characters. 
Retrospective validation:  
          This provides a review and evaluation of existing information for comparison when 
historical data is sufficient and readily available. Retrospective validation is acceptable 
provided specific test results generated by reliable analysis. 
Concurrent:  
          Concurrent validation verifies the quality characteristics of a particular batch and 
provides assurance that the same quality would be attained again when subsequent 
batches are manufactured and analyzed under similar conditions.(P.D Sethi, 2008)     
The types of analytical procedures used for validation are 
* Identification tests.  
* Quantitative tests for impurity content. 
* Limit tests for the control of impurities. 
* Quantitative tests of the active moiety in samples of substance. 
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Identification tests:  
          They are intended to ensure the identity of an analyte in a sample. This is normally 
achieved by comparison of a property of the sample like spectrum, chromatographic 
behavior, chemical reactivity, etc. to that of a reference standard. 
Test for impurities:  
          The testing for impurities can be a quantitative test or a limit test. Either test is 
intended to accurately reflect the purity characteristics of the sample. Different validation 
characteristics are required for a quantitative test than for a limit test. 
Quantitative test:  
           Assay procedures are intended to measure the analyte present in a given sample. It 
represents a quantitative measurement of the major component(s) present in the drug.   
Reasons for validation 
*         Enables scientists to communicate scientifically and effectively on    
           technical matters 
* Setting standards of evaluation procedure for checking complaints   
           and taking remedial measures. 
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* Retrospective validation is useful for trend comparison of results  
           compliance to CGMP/GLP. 
* Closer interaction with pharmacopoeia harmonization particularly  
          in respect to determination of impurities and their limits. 
* For taking appropriate action, in case of non-compliance. 
* Economic: The consistency and reliability of validated analytical  
           procedure is to produce a quality product with all the quality  
           attributes, thus providing indirect cost saving from reduced testing  
           or retesting and elimination of product rejection. 
* As quality control process is not static, some form of validation/    
           verification should continue till the validated process is in use. 
 
Validation parameters (ICH  Code Q2AC Guideline) 
        The objective of the analytical procedure should be clearly understood since this will 
govern the validation characteristics which need to be evaluated .The typical validation 
characteristics that are to be considered are listed below: 
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 Accuracy 
 Precision 
 Specificity 
 Detection Limit  
 Quantization Limit   
 Linearity 
 Range  
 Robustness 
Specificity 
        Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Typically these might include 
impurities, degradants, matrix, etc. Lack of specificity of an individual analytical 
procedure may be compensated by other supporting analytical procedure(s). 
Accuracy (Trueness) 
        The accuracy of an analytical procedure expresses the closeness of the test results 
obtained by that method to the true value (a conventional true value or an accepted 
reference) 
        Accuracy is calculated as the percentage of recovery by the assay of the known 
added amount of analyte in the sample, or as the difference between mean and the 
accepted true value, together with confidence intervals. 
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      The ICH documents recommend that accuracy be assessed using a minimum of nine 
determinations over a minimum of three concentration level covering the specified range 
(i.e., three concentrations and three replicates of each concentration) 
Precision 
      The precision of an analytical procedure is the degree of agreement among the 
individual test result when the method is applied repeatedly the multiple samplings of a 
homogeneous sample under the prescribed conditions. Precision of an analytical 
procedure is usually expressed as the standard deviation or relative standard deviation 
(Coefficient of variation) of a series of measurements. Precision may be a measure of 
either the degree of reproducibility or repeatability of the analytical method under 
operating conditions. 
Repeatability:  
        It refers to the use of the analytical procedure within the laboratory over a short 
period of time using the same analyst with same equipment. 
Reproducibility:  
        It refers to the use of analytical procedure in different laboratories as in a 
collaborative study. 
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Intermediate precision:  
       It expresses within laboratory variation, on the different days or different analysts or 
equipment within the same laboratory. ICH documents recommend that repeatability 
should be assessed using a minimum of nine determinations covering the specified range 
for the procedure. (i.e., three concentrations) or a minimum of six determinations at 
100% of the test concentration) 
Specificity 
       Specificity is the ability to assess unequivocally the analyte in the presence of 
components which may be expected to be present. Lack of specificity of an individual 
procedure may be compensated by other supporting analytical procedures. 
Detection limit 
       The detection limit of an individual analytical procedure is the lowest amount of 
analyte in a sample, which can be detected but not necessarily quantitated as an exact 
value. Based on the standard deviation of the response and the slope, the detection limit 
of detection (LOD) may be expressed as DL=3.3σ/S, where σ is the standard deviation of 
the response and S is the slope of the calibration curve (of the analyte) 
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Quantitation limit  
        The quantitation limit of an individual analytical procedure is the lowest amount of 
analyte in a sample which can be quantitatively determined with suitable precision and 
accuracy.   It is a parameter used particularly for the determination of impurities and/or 
degradation products.   The quantization limit expressed as the concentration of analyte 
(e.g., percentage parts per million) in the sample. 
LOQ= 10σ/S 
         Where σ = residual standard deviation of the response; S= slope of the calibration 
curve  (of the  analyte) 
Linearity 
         The linearity of an analytical procedure is its ability (within a given range) to obtain 
test results which are directly proportional to the concentration of analyte in the sample. 
Range 
         The range of an analytical procedure is the interval between the upper and lower 
concentration (amount) of analyte in the sample (including these concentrations) for 
which it has been demonstrated that the analytical procedure has a suitable level of 
precision, and linearity. 
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Ruggedness 
       The ruggedness of an analytical method is the degree of reproducibility of test results 
obtained by the analysis of the same sample under variety of conditions, such as different 
laboratories, analysts, instruments, lots of reagents, elapsed times, assay temperatures or 
days. Intermediate precision can be considered as ruggedness. 
Robustness 
       The robustness of an analytical is a measure of its capacity to remain unaffected by 
small deliberate variations in methods parameters and provides an indication of its 
reliability during normal usage. 
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REVIEW OF LITERATURE 
Eda Satana and Sadi Altany., et al., (2001) designed the first-derivative Ultraviolet 
spectrophotometry and LC of simultaneous determination of Valsartan and 
hydrochlorothiazide in tablets. 
Noriko Daneshtalab., et al., (2002) developed an assay method for the quantitation of 
the angiotensin II receptor antagonist valsartan in human plasma using a liquid extraction 
method. It is a convenient method which is suitable for pharmacokinetic studies. 
Jingkai Gu., et al., (2007) developed a liquid chromatography/tandem mass 
spectrometry method for the simultaneous quantification of valsartan and 
hydrochlorothiazide in human plasma which was successfully employed in a 
pharmacokinetic study. 
Nozomu Kosek., et al., (2007) carried out a method for the quantitative determination of 
valsartan in human plasma by liquid chromatography-tandem mass spectrometry       
(LC-MS) 
Chitlange SS., et al., (2008) described a precise, accurate and reproducible reverse phase 
High Performance Liquid chromatographic (RP-HPLC) method for estimation of 
amlodipine besylate and valsartan. 
Oskar Gonzalez., et al., (2009) developed SPE-HPLC-PDA- fluorescence method for 
the simultaneous determination of drugs used in combined cardiovascular therapy in 
human plasma. 
Bhatia M. Sudesh., et al., (2009) determined valsartan and its degradation products by 
isocratic HPLC. 
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K.R.Gupta., et al., (2010) developed simultaneous estimation of valsartan and 
amlodipine and in their combined dosage form by UV spectrophotometric methods and 
validated the developed method. 
Ch.Krishnaiah., et al., (2010) developed stability-indicating gradient reverse phase 
ultra-performance liquid chromatographic (RP-UPLC) to determine their degradation 
products in active pharmaceutical ingredient and dosage form. 
Ch Sharadha., et al., (2010) developed validated RP-HPLC method for the quantitative 
estimation of valsartan in bulk and pharmaceutical dosage forms. 
Chaudhary Ankit., et al., (2010) estimated Valsartan & Nebivolol in pharmaceutical 
dosage forms by absorption ratio method. 
Gaikwad AV., et al., (2011) carried out the simultaneous estimation of ramipril and 
valsartan in capsules by HPTLC as per ICH guidelines. 
Anandakumar K., et al., (2011) designed an accurate and precise UV-
spectrophotometric absorption correction method for simultaneous determination of 
amlodipine besylate, valsartan hydrochlorothiazide in bulk and  in combined tablet  
dosage   form.  
Romina., et al., (2011) determined the characterized two new potential impurities of 
valsartan obtained under photo degradation stress condition. 
Bhaskara Raju V., et al., (2011) performed reversed phase HPLC analysis of Valsartan 
in pharmaceutical dosage forms. 
 
Della Grace Thomas Parambi., et al., (2011) developed a validated stability indicating 
HPLC method for the determination of valsartan in tablet dosage forms. 
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DRUG PROFILE 
Valsartan 
 
     Valsartan is N-Pentanonyl- N-{2” (1H- tetrazol-5-yl) biphenyl-4-ylmethyl} –L-Valine 
 
Empirical formula:    C24H29N5O3 
 
Molecular weight:    435.5g/mol 
 
Structure: 
 
                     
 
Description 
 
    A white to almost white powder. 
 
Melting point 
 
    116-117ºC 
 
Solubility 
    The soluble in chloroform, and ethanol, methanol  phosphate buffer pH4, 0.1 N 
Sodium hydroxide, and  insoluble in 0.1 N Hydrochloric acid.
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Mechanism of action 
       The final active messenger of the renin-angiotensin pathway is angiotensin II. 
Angiotensin II binds to Angiotensin1 receptors to cause vasoconstriction and fluid 
retention, both of which lead to an increase in blood pressure. The angiotensin II receptor 
blockers lower blood pressure by blocking the AT1 receptors. Therefore they have 
similar effects to angiotensin converting enzyme (ACE) inhibitors, which inhibit the 
synthesis of angiotensin II by ACE. However, non-ACE pathways can produce some 
angiotensin II. ACE inhibitors also decrease bradykinin breakdown and this action could 
be involved in some of the beneficial and adverse effects of that class of drugs. 
Therefore, a potential for differential clinical effects exists for these two classes of drugs. 
Contra indications 
      Hypersensitivity; severe hepatic impairment, cirrhosis or biliary obstruction; primary 
hyperaldosteronism. Pregnancy (2nd and 3rd trimesters) and lactation.  
Adverse drug reaction 
      Dizziness; headache; dose-related orthostatic hypotension; rash; angioedema; 
hyperkalaemia; myalgia; resp tract disorders; back pain; GI disturbances; fatigue; 
increase in BUN and serum creatinine; abdominal pain; dry cough; LFT elevations. 
 
Potentially Fatal 
     Blood dyscrasias (e.g. neutropenia). 
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Drug interaction 
       Increased risk of renal impairment and hyperkalaemia with NSAIDs and ciclosporin. 
Increased risk of hypotension with general anaesthetics, clozapine, dopamine agonists 
and other antihypertensives. Increased risk of lithium toxicity. Increased risk of 
hyperkalaemia with potassium-sparing diuretics, potassium supplements, ACE inhibitors, 
and heparin. 
Dosage forms 
     Only oral dosage form is available.  
Dosage: Adult 
     Initially, 80 mg once daily, increased to 160 mg. Max: 320mg  
Elderly 
     > 75 yr: Initially, 40 mg once daily. 
Brands 
     Diovan, Valzaar 
Precaution 
     Volume depletion; renal artery stenosis; monitor serum potassium concentrations; 
severe CHF; renal impairment; mild to moderate hepatic impairment, elderly. 
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AIM AND OBJECTIVE OF THE WORK 
          Standard analytical techniques are not available in the pharmacopoeias for newer 
drugs. So it becomes necessary to develop new analytical techniques for the newer drugs. 
Valsartan is one of the new drugs launched recently. The review of literature reveals that 
analytical techniques like HPLC, HPTLC, LC/MS have been reported for valsartan 
individually and in combination with other drugs but there is no evidence for the study of 
valsartan by UV using 0.1N sodium hydroxide, colorimetry involving acid dye method 
and quantitative NMR. 
          Thus the main objective of the work is to develop a simple, easy to perform, cost 
effective, accurate, precise and validated UV-Visible and qNMR  methods for the 
estimation of Valsartan in bulk and tablet dosage forms. The methods developed include: 
 UV Spectroscopy 
 Standard comparison method 
 Area Under the Curve 
 Derivative spectroscopy 
           (First derivative, Second derivative) 
 Q-Absorbance Method 
 Visible Spectroscopy- Acid dye method 
 Bromophenol and phosphate buffer pH 4  
Bromothymol blue and phosphate buffer pH 4 
 Q NMR – Quantization 
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MATERIALS AND METHODS 
 
Instrument employed 
            Shimadzu UV-Visible spectrophotometer, Model 1650 PC 
 
Preparation of the standard stock solution 
      Aliquot quantity of standard valsartan was weighed in 100mL volumetric flasks. 
Dissolved in 10 ml of 0.1N sodium hydroxide and made up to volume with 0.1N sodium 
hydroxide. Dilutions ranging from 5-30µg/ml of standard valsartan solutions were 
prepared using 0.1N sodium hydroxide.  
 
Preparation of the sample stock solution 
       The average weights of twenty tablets were accurately determined and powdered. 
Powdered sample equivalent to 100 mg of VAL was accurately weighed and transferred 
into a 100ml volumetric flask. The content was dissolved in 0.1N sodium hydroxide and 
shaken well. The solution was then allowed to stand for few minutes and made up to 
volume with 0.1N sodium hydroxide and filtered. The first few mL of the filtrate was 
discarded and the remaining solution was used for analysis.  
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ESTIMATION BY UV-SPECTROPHOTOMETRY (Metreyi 2008) 
Most organic compounds absorb UV or visible light making them susceptible for 
quantification using spectrophotometers. Ultraviolet spectroscopy involves the 
measurement of light absorbed by the analyte present in the range of 200-350nm. The use 
of UV for quantitative analysis employs the method of comparing the absorbance of 
standards and samples at a selected wavelength  
 
Criteria to select the procedure includes 
 Conformity to Beer-Lamberts’ law. 
 Degree of selectivity and specificity. 
 Stability of absorbance with respect to time, pH, ionic strength and temperature. 
Establishment of various parameters 
 Absorption maximum 
 Beer’s concentration   
 Calibration graph 
 Estimation of analyte in dosage form 
 Recovery studies 
Absorption Maximum 
The standard stock solution was suitably diluted in 0.1N sodium hydroxide to 
yield a concentration of 10µg/mL. This solution was scanned in the UV region between 
200-400nm using 0.1N sodium hydroxide as blank. It was found that VAL exhibited an 
intense maximum absorption at about 247nm.Fig-1 
 
Department of Pharmaceutical Chemistry Page 28 
 
Fig-1 Absorption  Spectra at 247nm 
     
 
 
Selection of Solvent 
  The drug was found to be soluble in 0.1N sodium hydroxide.So, 0.1N sodium 
hydroxide was selected for the studies of valsartan by UV spectroscopy.  
Beer’s Concentration to confirm the linearity range  
Aliquots of standard solution of VAL were suitably diluted to give varying 
concentrations ranging of 5-30µg/mL. The absorbances were measured at about 249nm 
and values are presented in Table-1.  
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Table 1: Absorbance of VAL at 249nm 
Sl. No. 
Concentration 
(in µg/mL) 
Absorbance* 
1 5 0.151 
2 10 0.305 
3 15 0.471 
4 20 0.579 
5 25 0.735 
6 30 0.888 
   *Each value is the mean of three readings 
Calibration graph 
    A graph of absorbance against concentration was plotted. From the graph the 
Beer’s law concentration for the analyte was found to be between 5-30µg/mL(Fig-2). 
     
         Fig 2: Calibration chart of VAL 
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Fig 3: Overlain spectra of VAL 
           
 
Analysis of sample 
      The sample solution was further diluted with 0.1N sodium hydroxide and the 
absorbance of the solution was then measured at 249nm using 0.1N sodium 
hydroxide as blank. The amount of VAL was calculated using the formula 
                             
 
     
 
 
                          
Amount present 
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 Table 2: Results of Assay of VAL using Standard absorbance method 
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
39.8 ± 0.00012 0.0031 99.48 ± 0.309 0.0031 
2. 40.01 ± 0.00010 0.0026 100.25 ± 0.268 0.0026 
3. 40.01 ± 0.00024 0.0061 100.36 ± 0.619 0.0061 
   *Each value is the mean of three determinations 
Recovery studies  
        To study the accuracy, precision and reproducibility of the proposed method, 
recovery studies were carried out by adding a known quantity of drug to pre-analyzed 
sample and the percentage recovery was calculated and the results obtained are 
presented in Table-3. 
Table 3: Results of Recovery Studies of VAL using  
Standard Absorbance method 
Ex
pe
ct
ed
 
%
 
R
ec
o
v
er
y 
Amount of 
Drug Added 
in mg 
Total 
Amount 
Assayed 
(mg) * 
Amount 
Rcovered 
(mg) 
Assessed 
% 
Recovery 
% Recovered  
± S.D 
% 
RSD 
Sa
m
pl
e 
St
a
n
da
rd
 
20% 
40mg 
8 47.81 8.11 20.26 101.34 ± 0.154 0.0076 
50% 20 59.78 20.07 50.17 100.35 ± 0.309 0.0061 
100% 40 80.07 40.03 100.90 100.90 ± 0.268 0.002 
    *Each value is the mean of three determinations. 
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METHOD 2: AREA UNDER CURVE METHOD (Niraimathi V, et al., (2010) 
         This method is applicable when there is no peak or when broad spectra are 
obtained. It involves the calculation of integrated value of absorbance with respect to 
the wavelength between two selected wavelengths λ1 and λ2. The inbuilt software 
calculates the area bound by the curve and the horizontal axis. The horizontal axis is 
selected by entering the wavelength range over which the area has to be calculated. 
The wavelength range is selected on the basis of repeated observations so as to get the 
linearity between area under curve and concentration (Mukesh, 2007). 
Establishment of various parameters  
 Area under the curve  
 Linearity  
 Calibration graph 
 Estimation of analyte in dosage from 
 Recovery studies 
 
Area under curve 
        The standard stock solution was suitably diluted in 0.1N sodium hydroxide 
to yield a concentrations ranging from 5-30µg/mL. This solution was scanned in the 
UV region between 200-350nm using 0.1N sodium hydroxide as blank. The 
calibration graph was plotted against AUC and the linearity was established. The 
sample AUC was interpolated on the respective linearity chart of the AUC and the 
concentration was determined.  The two selected wavelength chosen for  AUC 
determined was between 238-254nm. 
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Fig 4: AUC of VAL between 238-254nm. 
                                
Linearity range 
      The AUC obtained for different concentrations of standard solution of VAL 
are presented in Table4. 
                               Table -4: AUC of VAL between 238-254 
 
 
 
*Each value is the mean of three determinations 
Sl. No. 
Concentration 
(in µg/mL) 
Absorbance* 
1 5 0.068 
2 10 0.137 
3 15 0.209 
4 20 0.282 
5 25 0.358 
6 30 0.432 
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Calibration graph 
           A graph of AUC against concentration was plotted. From the graph, it was 
found that the drug obeyed linearity in the range 5-30µg/mL (Fig-5.) 
Fig 5: Calibration graph of VAL by AUC method 
 
Analysis of sample 
         The sample solution was suitably diluted and was scanned in the spectrum 
mode and AUC was calculated in the wavelength range 238-254 nm. The AUC so 
obtained was interpolated on the calibration graph and the concentration of sample 
determined. The amount present per tablet was calculated and presented in Table-5. 
        Table 5: Results of Assay of VAL using AUC 
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
40.04 ± 0.0004 0.0094 100.91 ± 0.9451 0.0094 
2. 39.60 ± 0.0004 0.0096 98.91 ± 0.9451 0.0096 
3. 40.01 ± 0.00070 0.0163 100.24 ± 1.6370 0.0163 
   *Each value is the mean of three determinations 
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Recovery studies  
To study the accuracy, precision and reproducibility of the proposed method, the 
recovery studies were carried out on spiked samples by adding predetermined amount of 
standard drugs to the respective sample. About 20, 40 and 100% of standard drugs were 
added to the sample solutions and the absorbance was measured against methanol blank. 
The percentage recovered was calculated and presented in Table -6. 
Table 6: Results of Recovery Studies of VAL using AUC 
Ex
pe
ct
ed
 
%
 
R
ec
o
v
er
y 
Amount of 
Drug Added 
in mg 
Total 
Amount 
Assayed 
(mg) * 
Amount 
Rcovered 
(mg) 
Assessed 
% 
Recovery 
% Recovered  
± S.D 
% 
RSD 
Sa
m
pl
e 
St
a
n
da
rd
 
20% 
40mg 
8 48.9 8.05 20.11 100.58 ± 0.094 0.0047 
50% 20 60.08 19.90 49.78 99.58 ± 1.25 0.0251 
100% 40 80.10 40.10 100.18 100.18 ± 0.094 0.0009 
*Each value is the mean of three determinations. 
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METHOD 3: FIRST DERIVATIVE SPECTROSCOPY (Chatwal 2005) 
          
        Derivative spectrophotometry involves the transformation of absorption spectra into 
first, second or higher order derivative spectra. In derivative spectroscopy, the ability to 
detect and to measure minor spectral features is considerably enhanced. It can be used in 
quantitative analysis to measure the concentration of an analyte whose peak is obscured 
by a larger overlapping peak. It is useful in eliminating matrix interference in the assay of 
many medicinal substances. Derivative spectrum is done by wavelength modulation with 
dual wavelength photometers and microprocessor controlled digital photometer. 
       Normal spectrum is a zero order spectrum. The first derivative (D1) spectrum is a 
plot of the gradient of absorption curve (rate of change of absorbance with wavelength ie. 
dA/dλ Vs λ) against wavelength. It is characterized by a maximum, minimum and a cross 
over point at the λ max of the absorption band                
  Advantages: 
 Accurate determination of λ max is possible. 
1. Increased resolution permits the selective determination of certain absorbing 
substances. 
2. Absorption bands can be recognized when there are two or more absorption bands 
overlapping at the same or slightly different wavelength. 
        For quantification, peak heights (in mm) are usually measured. The amplitude is the 
distance from the maximum to the minimum at the λ max (which is the zero crossing in 
the spectrum) in first order. The amplitude of positive or negative peaks at the cross over 
point is directly proportional to the concentration. 
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Establishment of optimum parameters 
    The standard stock solution of VAL was suitably diluted to give the various 
concentrations ranging from 5-30µg/mL .These solutions were scanned between 200-
400nm and the primary absorption spectra were recorded. The primary spectrum was 
then derivatized  for the first order (Fig 6 ) 
             
                Fig -6: Overlain spectra of first derivative of Valsartan 
 
 
      The primary spectrum was then derivatized to the first order using derivative mode. 
The amplitude of the negative peak maximum at the zero crossing of the first order curve 
was measured in mm at 247nm and is presented in Table-7.   
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              Table 7: Valsartan in mm for first derivative spectrum 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                    
 
                            *Each value is the mean of three determinations. 
 
Calibration graph 
      A graph was constructed by plotting amplitude against concentration and is shown in 
Fig.7 for first order. The Beer’s Law was obeyed in the range of 5-30µg/mL for first 
derivative spectroscopic method. 
 
 
 
 
Sl. No. 
Concentration 
(in µg/mL) 
First Derviative 
Amplitude (mm)* 
1 5 0.4 
2 10 0.7 
3 15 1.0 
4 20 1.3 
5 25 1.6 
6 30 
1.9 
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         Fig 7: Calibration graph of VAL by first derivative spectroscopy 
 
 
Analysis of sample solution 
       The sample solution was suitably diluted and scanned between 200-400nm using 
0.1N sodium hydroxide as blank and the primary spectrum obtained was derivatized for 
first order derivative. The amplitude (DL) of the peak maximum and minimum at the 
zero crossing of the first order curve (i.e. λmax of the fundamental spectrum) was 
measured in mm. The amount of drug present was found by interpolation on the 
calibration graph and the amount of drug present per tablet was calculated by using the 
formula and the assay results are given in the Table 8 
 
 Amount present       
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Table 8: Results of Assay and Precision of VAL  
                (First derivative spectroscopy) 
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
39.8 ± 0.0008 0.0190 98.24 ± 1.8903 0.0190 
2. 40.1 ± 0.0005 0.0123 100.44 ± 1.2349 0.0123 
3. 40.1 ± 0.0007 0.0163 100.24 ± 1.6370 0.0163 
   *Each value is the mean of three determinations 
Recovery Studies 
     To study the accuracy, precision and reproducibility of the proposed method, recovery 
study was carried out by adding a known quantity of drug to preanalysed sample and the 
percentage recovery was calculated and the results obtained are presented in Table-9 
Table 9: Results of Recovery Studies of VAL  
          (First derivative spectroscopy) 
Ex
pe
ct
ed
 
%
 
R
ec
o
v
er
y 
Amount of Drug 
Added 
in mg 
Total 
Amount 
Assayed 
(mg) * 
Amount 
Rcovered 
(mg) 
Assessed 
% 
Recovery 
% Recovered  
± S.D 
% 
RSD 
Sa
m
pl
e 
St
a
n
da
rd
 
20% 
40mg 
8 48.01 8.10 20.18 100.90 ± 0.00004 0.0047 
50% 20 60.18 20.24 50.59 101.18 ± 0.00004 0.0019 
100% 40 79.58 39.60 99.11 99.11 ± 0.0001 0.0034 
   *Each value is the mean of three determinations. 
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METHOD 4: SECOND DERIVATIVE SPECTROSCOPY (Beckett,1997)            
 
       Normal spectrum is a zero order spectrum. The primary spectrum obtained for the 
above was then derivatized for the second order. The second derivative spectrum (D2) is 
a plot of curvature of the absorption spectrum against wavelength (d2 A / dλ2 Vs λ). The 
amplitude (DL) of long wave peak satellite of the second order curve was measured. The 
amplitude of the negative peak maximum corresponding to λmax of fundamental 
spectrum was measured. 
Establishment of optimum parameters 
     The standard stock solution was suitably diluted to give the various concentrations 
ranging from 5-30µg/mL. These solutions were scanned between 200-400nm and the 
primary absorption spectra were recorded. The primary spectrum was then derivatized to 
the second order (Fig. 8) 
Fig 8: Calibration graph of VAL by second derivative spectroscopy 
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    The primary spectrum obtained above was then derivatized to the second order. The 
amplitude of the negative peak maximum was measured in mm at 247nm and is 
presented in Table-10 
Table 10: Ampitude in mm for second derivative spectrum 
Sl. No. 
Concentration 
(in µg/mL) 
First Derviative 
Amplitude (mm)* 
1 5 7 
2 10 14 
3 15 21 
4 20 28 
5 25 35 
6 30 41 
 
                         *Each value is the mean of three determinations. 
Calibration graph 
    A graph was constructed by plotting amplitude against concentration and is shown in 
Fig. 9 for the second order. The Beer’s Law was obeyed in the range of 5-30µg/mL for 
second derivative spectroscopic method. 
Fig 9 Calibration graph of VAL by second derivative spectroscopy 
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   Analysis of sample solution  
      The sample solution was suitably diluted and scanned between 200-400nm using 
0.1N sodium hydroxide as blank and the primary spectrum obtained was derivatized for 
second order derivative. The amplitude (DL) of long wave peak satellite of the second 
order curve (i.e. λmax of the fundamental spectrum) was measured in mm. The amount 
of drug present was found by interpolation on the calibration graph and the amount 
present per tablet was calculated.The assay results are presented in the Table 11 
     Table 11: Results of Assay and Precision of VAL  
                 (Second derivative spectroscopy) 
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
39.8 ± 0.00012 0.0031 99.48 ± 0.309 0.0031 
2. 40.01 ± 0.00010 0.0026 100.25 ± 0.268 0.0026 
3. 40.01 ± 0.00024 0.0061 100.36 ± 0.619 0.0061 
   *Each value is the mean of three determinations 
 
Recovery studies 
       To study the accuracy, precision and reproducibility of the proposed method, 
recovery study was carried out by adding a known quantity of drug to preanalysed sample 
and the percentage recovery was calculated the results obtained are presented in Table 12 
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Table12: Results of Recovery Studies of VAL 
           (Second derivative spectroscopy) 
Ex
pe
ct
ed
 
%
 
R
ec
o
v
er
y 
Amount of 
Drug 
Added 
in mg 
Total 
Amount 
Assayed 
(mg) * 
Amount 
Rcovered 
(mg) 
Assessed 
% 
Recover
y 
% Recovered  
± S.D 
% 
RSD 
Sa
m
pl
e 
St
a
n
da
rd
 
20% 
40mg 
8 48.9 8.05 20.11 100.58 ± 
0.094 
0.004
7 
50% 20 60.08 19.90 49.78 99.58 ± 1.25 0.025
1 
100% 40 80.10 40.10 100.18 100.18 ± 
0.094 
0.000
9 
    *Each value is the mean of three determinations. 
 
 
  
 
 
 
 
 
 
 
 
 
 
Department of Pharmaceutical Chemistry Page 45 
 
METHOD 5: Q- ABSORBANCE METHOD (Priyadarshini J, et al., 2010) 
       Q- absorbance method depends on the property that, for a substance which obeys 
Beer’s Law at all wavelength, the ratio of absorbances at two wavelengths is a constant 
value independent of concentration or pathlength (Beckett, 1997 ). The wavelengths 
selected for this method are 235 nm to 250nm. The ratio of absorbances between these 
two wavelengths was calculated. The values obtained by the proposed method are 
presented in Table-13 
 
Table 13: Ratio of absorbances at 235 nm and 250 nm 
S.No Concentration (µg/mL) 
Absorbance 
at 235nm 
Absorbance 
at 250nm 
Ratio of 
absorbance* 
1 5 0.161 0.150 1.07 
2 10 0.325 0.302 1.07 
3 15 0.502 0.466 1.07 
4 20 0.615 0.574 1.07 
5 25 0.782 0.727 1.07 
6 30 0.937 0.874 1.07 
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Establishment of optimum parameters 
      The standard stock solution of VAL was suitably diluted to give the various 
concentrations ranging from 5-30µg/mL. These solutions were scanned between 200-
400nm and the primary absorption spectra were recorded. It was found that VAL 
exhibited an intense maximum absorption at about 235nm . The two wavelengths chosen 
for this method are 235-250nm respectively.                                     
Analysis of Sample solution  
      The sample solution was suitably diluted and scanned between 200-400nm using 
0.1N sodium hydroxide as blank and the absorbance of the solution was then measured at 
235nm and 250nm using 0.1N sodium hydroxide as blank. The ratio of absorbances 
between these two wavelengths was calculated. The results are tabulated in Table 14 
Table14: Results of Assay and Precision of VAL  
(Q  Absorbance) 
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
39.9 ± 0.00010 0.0027 99.76 ± 0.2739 0.0027 
2. 39.9 ± 0.00017 0.0043 99.98 ± 0.4320 0.0043 
3. 39.80 ± 0.00011 0.0027 99.57 ± 0.2739 0.0027 
   *Each value is the mean of three determinations 
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VISIBLE SPECTROPHOTOMETRY METHOD 
(COLORIMETRY) 
    
       Colorimetry (Vogel, 1989) involves the measurement of amount of visible radiation 
absorbed by substance in the solution. The wavelength between 400-800nm is considered 
to be visible region. The use of visible spectroscopy for quantitative analysis employs the 
method of comparing the absorbance of reference standards and samples at a selected 
wavelength. Various colorimetric methods include oxidation or reduction, diazotization 
followed by coupling, complexing with metal ion pair complexes with indicator  dyes etc. 
Advantages of colorimetric procedures 
 A colorimetric method will often give more accurate results at low concentrations 
than the corresponding titrimetric or gravimetric procedure. 
 It may be simpler to carry out. 
 It may be frequently applied under conditions where no satisfactory gravimetric 
or titrimetric procedure exists. 
 It possesses advantages over the routine determination of some components of a 
number of similar samples may be made  
  
The criteria for the selection of procedure include: 
• Specificity of the colour reaction    
• Proportionality between colour and concentration  
• Stability of the colour  
• Reproducibility 
• Clarity of the solution 
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• High sensitivity 
• Stability of absorbance with respect to time, variation of pH,ionic strength and 
temperature. 
• Degree of selectivity of complexing agent includes the effect of other species 
likely to be present 
• Conformity to the Beer-Lambert’s law and plot calibration data for the range of 
concentration measured. 
 
METHOD 6: CHARGE TRANSFER COMPLEX METHOD 
(Acid- Dye Method) Higuchi 1997 
   This method is based on the formation of colored ion-pair complex on 
utilization of acidic dyes as analytical reagents. The ion-pair complex is special form of 
molecular complex resulting from two components i.e the ionized analyte and an acid dye 
at suitable (pH 4).  
           The addition of an amine in its ionised form to an ionized acidic dye, e.g. 
bromocresol green, bromothymol blue, yields a salt (ion-pair).The indicator dye is added 
in excess and the pH of the aqueous solution is adjusted if necessary to a value where 
both the analyte and dye are in the ionised forms.The molar absorptivities of the ion-pairs 
formed between quaternary ammonium compounds and bromothymol blue are typically 2 
x 104 -4 x 104. The acid-dye method therefore provides a more sensitive technique for 
certain analyte and quaternary ammonium compounds that absorb weakly in the 
ultraviolet region. The correct choice of pH may permit the selective assay of a mixture 
of an analyte and a quaternary ammonium salt.      
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Reagents and chemicals 
0.1N sodium hydroxide  as per I.P 
Bromophenol blue solution (0.1%) as per I.P 1996 (P.A-202) 
Phosphate buffer pH 4 as per I.P 1996 (P.A-146) 
 
Method A: Bromophenol  blue and phosphate buffer pH 4     
Preparation of reagents 
Bromophenol blue solution (0.1%) I.P 1996 (P.A-202) 
Ethanolic Bromophenol blue Solution: Dissolve 0.1g of bromophenol blue with 
gentle heating in 1.5mL of 0.1M Sodium hydroxide and 20mL of ethanol (95%) and add 
sufficient water to produce 100mL. 
Phosphate buffer pH 4 (IP, 1996 P.A-146) 
Dissolved 5.04 gm of disodium hydrogen phosphate and 3.01 gm of potassium 
dihydrogen phosphate in sufficient water to produce 1000mL, pH  adjusted with glacial 
acetic acid. 
Establishment of optimum levels of various parameters 
Absorption maximum 
Stability of color 
Beer’s concentration 
Calibration graph 
Estimation of analyte in dosage form 
Recovery studies 
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Stock solution (1mg /mL) 
50mg of pure valsartan was accurately weighed and transferred into 50mL 
volumetric standard flask and to that phosphate buffer was dissolved to dissolve the drug 
and made up to 50mL with phosphate buffer.  
 
Determination of Absorption Maximum (λmax) 
The stock solution was suitably diluted to get a concentration of 1000µg/mL. 
Further dilutions containing 1mL, 2mL, 3mL, 4mL and 5mL of stock solution were 
transferred in to six 10 mL volumetric flasks. To this was added 1mL of 0.1% 
Bromophenol blue solution and the volume made upto 10mL with phosphate buffer. 
Chromogen was determined by scanning in the visible region when yellow colouration 
changes to blue violet and the absorption maximum was found to be 622nm. The 
spectrum is shown is in Fig 10 
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Fig  10: Absorption maximum of ion-pair complex at 622nm 
               
 
 
Stability of colour 
  The absorbance of yellow to violet colour complex was measured at 622nm at 
30min, 1 hr and 2hr against reagent blank. The colour was stable for 3hrs. 
Evaluation of Beer’s Concentration 
  Aliquots of the standard stock solution were transferred to a series of 10mL 
volumetric flask, 1mL of 0.1% Bromophenol solutions were added to the respective 
flasks. The volumes were then made up using in phosphate buffer pH4. The absorbance 
of the solution was measured at 622nm using reagent blank.   
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The absorbances obtained are presented in Table 15 
Table 15 : Absorbance  VAL - at 622nm 
S.No Concentration (in µg/mL) Absorbance* 
1 100 0.216 
2 200 0.287 
3 300 0.352 
4 400 0.409 
5 500 0.461 
6 600 0.522 
                                     *Each value is the mean of three determination 
A buffer of pH 4 and a absorption maximum of 622nm was used for further studies 
Beer’s concentration 
According to Beer’s law, the graph was drawn by measuring the absorbance of 
various concentration of drug solution against the blank from stock solution (1µg/mL) of 
various concentrations 0.1mL, 0.2mL and 0.5mL were pipette out and transferred into 
25mL volumetric flask and make up with phosphate buffer. The drug concentration in 
each flask was 5µ/mL,         
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Calibration graph 
A graph was constructed by plotting the absorbance against concentration and is shown 
in Fig11.  It was observed that VAL obeyed Beer’s law in the concentration range of      
100-600µg/mL.  
Fig11: Calibration graph of Bromophenol Blue  
 
 
Analysis of Sample solution: 
Twenty tablets of VAL from the tablets were accurately and weighed and grand to 
fine powder. Tablet powder equivalent to 50mg of VAL was accurately weighed and 
shaken well with phosphate buffer for 20 minutes, and made up to volume with 
phosphate buffer to obtain a concentration of 1000µg/mL. The solution was filtered 
through Whatmann filter paper No.41.First 10 mL of the filtrate was discarded, and then 
1mL of the filtrate was transferred to a 10mL volumetric flask. The sample solution was 
treated with acid dye and the absorbance of the chromogen was measured at the 
maximum at about 622nm using reagent blank.  
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Table16 : Results of Assay and Precision of VAL  
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
40.32 ± 0.00005 0.0013 100.80 ± 0.1347 0.0013 
2. 40.39 ± 0.00010 0.0026 100.99 ± 0.2694 0.0026 
3. 40.47 ± 0.00016 0.0039 101.18 ± 0.4042 0.0039 
   *Each value is the mean of three determinations 
 
Recovery studies 
      To study the accuracy, precision and reproducibility of the proposed method, 
recovery study was carried out by adding a known quantity of drug to preanalysed sample 
and the percentage recovery was calculated and the results obtained are presented in 
Table 17 
 
 
 
 
 
 
Amount    
Present 
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Table 17: Results of Recovery Studies of VAL  
Ex
pe
ct
ed
 
%
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y 
Amount of 
Drug Added 
in mg 
Total 
Amount 
Assayed 
(mg) * 
Amount 
Rcovered 
(mg) 
Assessed 
% 
Recovery 
% Recovered  
± S.D 
% 
RSD 
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m
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e 
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20% 
40mg 
8 48.36 8.06 20.15 100.76 ± 0.233 0.0115 
50% 20 60.41 20.10 50.26 100.52±0.1347 0.0028 
100% 40 80.68 40.40 100.95 100.95 ± 0.1347 0.0013 
    *Each value is the mean of three determinations. 
METHOD B:  Acid dye using Bromothymol blue (L.Latheeshjlal 
Reagents and chemicals 
0.1N sodium hydroxide  
Bromothymol  blue solution (0.1%) 
Phosphate buffer pH 4 as per I.P 1996 (p.A-146) 
 
Preparation of reagents 
Bromothymol Blue Solution:  
Aqueous Bromothymol Blue Solution. Dissolve 50mg of bromothymol blue in 
4mL of 0.02M sodium hydroxide and 20mL of ethanol (95%).After solution is effected, 
add sufficient water to produce 100mL.   
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Phosphate buffer pH 4 
Dissolved 5.04 gm of disodium hydrogen phosphate and 3.01 gm of potassium 
dihydrogen phosphate in sufficient water to produce 1000mL, pH adjusted with glacial 
acetic acid  
Stock solution (1mg /mL) 
50mg of pure valsartan was accurately weighed and transferred into 50mL 
volumetric standard flask and dissolved in 0.1N sodium hydroxide. Finally made up to 
50mL with phosphate buffer 
Spectral characterization and Linearity Establishment 
A stock solution of VAL was prepared by dissolving accurately weighed quantity 
of standard VAL in phosphate buffer pH 4 and made up to volume with phosphate buffer 
pH 4 to obtain a concentration of 1000µg/mL.  From the stock solution 1.0, 2.0, 3.0, 4.0 
and 5.0 were transferred into five 25 mL volumetric flasks. The solutions were added a 
5mL of 0.1% of bromothymol blue solution and made upto 25mL with phosphate buffer, 
when red coloured changed in yellow colour. 
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Table18 : Absorbance  VAL - at 433nm 
S.No Concentration (in µg/mL) Absorbance* 
1 40 0.065 
2 80 0.135 
3 120 0.196 
4 160 0.279 
5 200 0.348 
6 240 0.429 
                                       *Each value is the mean of three determination 
                        Fig 12: Calibration graph of Bromothymol Blue  
 
 
 
 
Department of Pharmaceutical Chemistry Page 58 
 
Sample solution: 
Twenty tablets of VAL from the tablets were accurately and weighed and grand to 
fine powder. Tablet powder equivalent to 50mg of VAL was accurately weighed and 
dissolved in 1Msodium hydroxide and finally volume is made up with phosphate buffer 
to obtain a concentration of 1000µg/mL. The solution was filtered through Whatmann 
filter paper No.41. First 10 mL of the filtrate was discarded, and then 3mL  of the filtrate 
was transferred to a 25 mL volumetric flask. The sample solution was acidic dye 
complexed and the absorbance was measured using the same procedure as that of 
standard VAL. 
                   Fig 13 :Absorption maximum of ion-pair complex at 433nm. 
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Table 19: Results of Assay and Precision of VAL  
Sl. 
No. 
Label 
claim 
Amount present 
(in mg) ± SD* 
RSD % Purity ± SD % RSD 
1. 
40mg 
40.04 ± 0.0003 0.0083 100.01 ± 0.8382 0.0083 
2. 40.38 ± 0.00034 0.0086 100.95 ± 0.8724 0.0086 
3. 40.45 ± 0.00033 0.0082 101.12 ± 0.8382 0.0082 
   *Each value is the mean of three determinations 
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Recovery studies 
      To study the accuracy, precision and reproducibility of the proposed method, 
recovery study was carried out by adding a known quantity of drug to preanalysed sample 
and the percentage recovery was calculated and the results obtained are presented in  
Table 20: Results of Recovery Studies of VAL  
 
    *Each value is the mean of three determinations 
 
 
 
 
 
Ex
pe
ct
ed
 
%
 
R
ec
o
v
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y 
Amount of 
Drug Added 
in mg Total 
Amount 
Assayed 
(mg) * 
Amount 
Rcovered 
(mg) 
Assessed 
% 
Recovery 
% Recovered  
± S.D 
% 
RSD 
Sa
m
pl
e 
St
a
n
da
rd
 
20% 
40mg 
8 48.53 8.08 20.19 100.96 ± 0.241 0.0119 
50% 20 60.38 19.93 49.83 99.66±0.3988 0.0080 
100% 40 80.25 39.80 99.50 99.50 ± 0.4605 0.0046 
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PRACTICAL ASPECTS OF Q-NMR 
       High selectivity under appropriate acquisition condition with any available pure 
standard compound containing the nucleus of interest has made qNMR a popular method 
of analysis. There are a number of issues and parameter to be considered when measuring 
NMR spectra for quantitative analysis. Some of the parameters which ensures accurate 
and precise quantitative analysis are briefly given below: 
Internal Reference Standard (I.R.S). 
   The I.R.S chosen should be available in a pure state which can be structurally 
unrelated to the analyte but should contain the nucleus of interest and has a resonance 
that does not overlap with that of analyte. The other requirements for standards being, 
they are chemically inert, have low volatility, have similar solubility characters as the 
analyte and should have reasonable relaxation time. Based on these conditions. Tetra 
chloro nitro benzene (TCNB) which had the said characteristic was chosen as internal 
reference standard for our quantification.  
Internal standard and concentration of analyte 
     In qNMR spectrum the integrated intensity of a resonance due to analyte nuclei is 
directly proportional to its molar concentration and to the number of nuclei that give rise 
to that resonance. 
 
 On comparing the integral of an analyte resonance to that of standard compound of 
known     concentration, the analyte concentration can be determined.  
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 Normalized area std 
 
 
      The direct proportionality of the analytical response and molar concentration is a 
major advantage of NMR over other quantitative spectroscopy. (The Quantitative NMR 
Portal, http://tigger.uic.edu/~gfp/qnmr/ ) 
 
Choice of Nuclei 
A wide range of nuclei can be measured, with the spin ½ nuclei 1 H, 13C,15N, 19F, 
29Si and 31P above among the most common. Most qNMR experiments make use of 1H 
because of inherent sensitivity of this nucleus and its high relative abundance (nearly 
100%). Compared with other nuclei like 13C, 1H nuclei have more favorable T1 relaxation 
times.The choice of nuclei also depends on whether one nucleus universal detection (for 
organic compounds 1H, 13C, fall into this category) or selective detection (e.g fluoride 
ions in ppm level in water) 
Sample concentration 
 In NMR the signal detected scales linearly with concentration. Since qNMR is 
not a very sensitive method, reasonably concentrated samples are used, for protons this 
means analyte concentration will be in millimolar to molar range, depending upon the 
instrument. Other nuclei are less sensitive than proton (1H 100% abundance) (G.F.Pauli, 
2007) 
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ACQUISITION PARAMETERS  
Homogeneity of magnetic field 
The field homogeneity is adjusted through a process known as shimming. The 
NMR samples should be free of particulate matter because particles, hinder shimming, 
accurate shimming is important for integration. 
 
Number of Scans 
It is important to generate spectra that have a high signal-to-noise ratio to improve 
the precision of the determination. The signal to noise ratio should be higher than 1000:1 
for integration errors of less than 1% .This is achieved easily in spectrometers with 
indirect probes. (Engineer -2010) 
 
Acquisition Time 
  The acquisition time (AT) is the time after the pulse for which the signal is 
detected. Because the FID is a decaying signal, there is not much point in acquiring the 
FID for longer than 3 X T2 because at the point 95% of the signal will have decayed away 
into noise. Typical acquisition times in 1H NMR experiments are 1-5 sec. 
 
Repetition Time 
  The repetition time is the total time between the start of acquisition of the first 
FID and the start of acquisition of the second FID. The repetition time is the sum of the 
acquisition time and any additional relaxation delay inserted prior to the rf pulse.  
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Pulse Width 
  
The NMR signal is detected as a result of a radio frequency (rf) pulse that excites 
the nuclei in the sample. The pulse width is a calibrated parameter for each instrument 
and sample that is typically expressed in µs.   
Integration regions 
The shape of an NMR peak is given by the Lorentzian function L(x)= 
h/[1+(x/w)2], where h is the peak’s height and w is its line width at half height. 
Obviously, we can’t integrate every peak from -infinite to +infinite, so we must set a 
practical limit. Griffiths and Irving have shown that in order to cover 99.0% of the area of 
any peak, the region must spread over a range that is at least 25 times the line width of 
the peak in both directions. 
Baseline correction 
NMR integrals are calculated by summation of the intensities of the data points 
within the defined integration region. Therefore, a flat spectral baseline with near zero 
intensity is required.    
Materials and Methods 
All the chemicals used throughout the experiment are of highest purity analytical grade.  
Solvent used: Deuterated chloroform (CDCl3) was procured from Merck India Limited. 
Internal standard: tetra chloro nitro benzene  obtained from Merck India Limited. 
 Bulk material: Authentic sample of valsartan was generously gifted from Madras  
Pharmaceutical Limited. 
Dosage form:  valsartan was purchased from local market. 
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Instrumentation 
All 1H NMR spectra were acquired using JEOL AL 300 FT-NMR spectrometer 
operating at 300.13 MHz. 32 free induction decays (FIDs) were collected for each sample 
into 32,768 data points using a spectral width of 6,001.50Hz; digital resolution of 
32768/6001.5=5.459points /Hz and an acquisition of time of 5.46 seconds. The chemical 
shifts were referenced internally to tetra methyl silane (TMS, δ =0.0),  The spectrometer 
is equipped with 5 mm Z- gradient BB probe using 1H 90° pulse width of about 11 µs. 
Relaxation delay of 60s was applied during the analysis. The 1H NMR spectra were 
processed and handled using AL 300 software. 
Method 
Calibration of the standard 
An aliquot weighed quantity of the internal standard TCNB was dissolved in 
CDCl3 to obtain the concentration of 30mg/mL. The standard drug VSN was weighed 
and dissolved in the above prepared internal standard stock solution to obtain a 
concentration of 150.05mg/mL. The standard stock solution was further diluted to obtain 
12, 13.5, 15, 16.5 and 18mg/mL of VSN. The NMR spectra were recorded for each 
solution and calibration chart was plotted between integral value along Y-axis and 
concentration along X-axis. Two integral values one at 1.73ppm and the other at 4.9ppm 
were considered. 
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Fig14: NMR spectra of standard valsartan 
 
Fig15:Comparative NMR spectra of standard  and sample valsartan 
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Fig16 NMR spectra of sample valsartan with internal standard (TCNB) 
 
  
                     Fig17: Calibration chart of Valsartan at 1.73 ppm 
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Fig 18:Calibration chart of Valsartan at 4.90 ppm 
 
Assay 
Weighed 20 tablets of VSN and ground to fine powder. Accurately weighed tablet 
powder equivalent to 15mg of VSN and transferred to a 1mL standard flask. Weighed 
accurately 15mg of TCNB and transferred to the same standard flask. Added 1mL of 
CDCl3 and warmed gently   for 5 minutes, the mixture was sonicated for 2minutes and 
filtered through Whatmann filter paper No.41.  About 0.6mL of the solution was 
transferred into a 5mm NMR tube. The NMR patterns were then recorded under the 
given experimental condition and the signals corresponding to the chemical shift of 1.73, 
4.95, 7.74 ppm were integrated and further used for quantification. Six replicate analysis 
were performed to assess the precision. The concentration   of the analyte in the sample 
can be calculated using the given formula. 
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 Where,  and  are the integral value of the sample (VSN)  and internal stanadard,  
and  are the weight taken, 
 
and  are the molecular mass  and  and  are the  
number of protons under consideration  for sample (VSN)  and the internal standard 
respectively. Table:21 
 
Table21 : Results of assay of Valsartan 
*Each value is the mean of six determinations 
Accuracy and precision: 
     The precision of the developed method was assessed by performing the assay of the 
formulation for about six times. Accuracy of the method was ascertained by the standard 
addition technique (recovery). Known amount of the standard VSN was added to the 
previously analysed sample. This was performed on three spiked levels and the NMR 
patterns were recorded. Six replicate analysis of above said   procedure was 
performed.Table:22 
 
 
Drug 
Label 
claim 
Amount present 
± SD 
RSD 
% Purity* 
± SD 
RSD 
Valsartan 40 mg 39.19 ± 0.256 0.652 97.97±0.586 0.598 
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Sample Assay (Content of Valsartan on mg/tab) 
Precision-1 39.06 
Precision-2 39.36 
Precision-3 39.45 
Precision-4 39.44 
Precision-5 38.97 
Precision-6 38.87 
Mean 
SD 
% RSD 
39.19 
0.256 
0.652 
 
Table 22: Recovery studies 
Amount of drug 
added 
Recovery using integral value at 
1.73 ppm 
Recovery using integral value at 4.9 
ppm 
Tablet 
powder 
added 
Standard 
(VSN) 
mg/mL 
Amount 
Recovered 
mg/mL 
% Recovery 
± S.D 
RSD 
Amount 
Recovered* 
mg/mL 
% Recovery 
± S.D 
RSD 
15 
mg/ml 
12 
 
 
12.05 
100.35 ± 1.44 
 
1.44 
 
12.05 
100.38 ± 1.55 
 
1.15 
15.01 
 
15.01z 
100.08 ± 0.74 
 
0.73 15.07 
100.43 ± 0.75 
 
0.75 
18.01 
 
 
18.04 
100.23 ± 1.36 
 
1.36 18.05 
100.28 ± 1.83 
 
1.83 
*Each value is the mean of three determinations 
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RESULTS AND DISCUSSION 
 
Assignment of  1HNMR   Signals of VSN 
 
Structure formula of Valsartan is shown in the introduction part of this article. 
The multiplets from 0.938 to 1.001δ is attributed to the aliphatic (-CH3) protons. The 
signals at 1.7δ can be attributed to the H4 (-CH2) protons. The signal at 1.402 can be 
attributed to H5 (- CH2) protons. The singlets at 8.0δ could assigned to the H3 (-NH) 
proton of the tetrazole ring as they resonate downfield. The signals at 7.452δ and 7.519δ 
can be assigned to the aromatic protons H1 and H2. The signal at 2.5δ could be assigned 
to the H6 (-CH2) protons. The signals at 4.2 δ and 4.9 δ are due to the resonance of the (-
CH) protons. The –OH proton of the carboxylic acid group is off the chart to the left 
which is a characteristic of carboxyl hydrogen. The NMR spectrum of the blank i.e., 
TCNB in CDCl3, represented only a sharp single signal at 7.74δ due to the proton of 
TCNB at its 4th position. 
Characteristics of the internal standard 
2, 3, 5, 6- tetra chloro nitro benzene was used as the internal standard. TCNB was 
selected as the internal standard as it is chemically inert and is less volatile. The NMR 
studies of TCNB showed that it had a good acceptable relaxation time T1 and produces a 
sharp single signal due to single proton at the 4th position at a chemical shift of 7.74 ppm 
which does not overlap with the signals of the analyte VSN. TCNB was soluble in CDCl3 
same as that of the analyte VSN. Moreover TCNB is available in pure form and is a 
crystalline solid at room temperature and can be dried to remove water of hydration. 
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            SUMMARY AND CONCLUSION 
The present work entitled “Quantification of Valsartan by UV-Visible and NMR 
spectroscopy comprises of UV-Visible spectrophotometric method and QNMR methods 
for estimation of Valsartan. The Ultraviolet method involves the determination of 
Valsartan by different methods like standard absorbance method, area under curve, 
derivative spectroscopy and Q-absorbance method. The drug obeyed Beer’s law at the 
concentration of   5-30µg/mL. The correlation coefficient was found to be 0.99 for all the 
method. The low percentage RSD value shows that the methods developed are not 
affected by the presence of sample matrix (or) devoid of interference by the excipients. 
The visible method involve Acid dye complexation with Bromo thymol blue and Bromo 
phenol blue. Both the methods obeyed Beer’s law at the concentration of  100-600µg/mL 
for Bromo thymol blue and 40-240µg/mL for Bromo phenol blue. The correlation 
coefficients were within the limit, and RSD percentage was low. Thus the methods were 
precise, specific and accurate. 
The qNMR method of Quantification is a novel and sophisticated technique. 
TCNB has been used as the internal standard and the solvent used is CDCL3. The 
intergrated intensity of resonance of valsartan at 1.73 ppm and 4.9ppm were considered 
for the Quantification. The standard and the sample resonance were compared and the 
amount present was calculated. The precision studies and the recovery studies were 
performed. This method was precise and accurate though makes use of sophisticated and 
costlier instrument.        
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